J. Exp. Med.
© The Rockefeller University Press
0022-1007/97/05/1803/11 $2.00
Volume 185, Number 10, May 19, 1997 1803-1813

Altered Hapten Ligands Antagonize Trinitrophenyl-specific Cytotoxic T Cells and Block Internalization of Hapten-specific Receptors

By Tobias Preckel,^* Rudolf Grimm, Stefan Martin,^* and Hans Ulrich Weltzien^*

From the ^* Max-Planck-Institut für Immunbiologie, Stübeweg 51, D-79108 Freiburg, Germany; and  Hewlett Packard, D-76337 Waldbronn, Germany

Low molecular chemicals (haptens) frequently cause T cell-mediated adverse immune reactions. Our previous work provided evidence that hapten-specific T cells, in analogy to those specific for nominal peptide antigens, direct their TCR towards hapten-modified, MHC-associated peptides. We now demonstrate that trinitrophenyl (TNP)-specific, class I MHC-restricted CTL from mice may exhibit exquisite specificity for subtle structural details of these hapten determinants, surpassing even the specificity of immunoglobulins. More importantly, these CTL could be antagonized by ligands altered either in their peptide sequence or in their hapten structure. The system was employed to examine the molecular basis of T cell antagonism. Whereas agonists resulted in a dose-dependent downregulation of TCR in different mouse T cell clones, antagonistic peptides totally failed to do so despite engaging the specific TCR. Moreover, simultaneous presentation of antagonist and agonist on the same antigen presenting cell prevented TCR internalization. No signs of anergy or functional receptor inactivation were observed in CTL treated with antagonist-loaded target cells. Based on a serial triggering model of T cell activation, our data favor a model in which antagonists block T cell functions by competitively engaging the specific TCR in unproductive interactions.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Zhong, W., Reche, P. A., Lai, C.-C., Reinhold, B., Reinherz, E. L. (2003). Genome-wide Characterization of a Viral Cytotoxic T Lymphocyte Epitope Repertoire. J. Biol. Chem. 278: 45135-45144 [Abstract] [Full Text]  
• Chmielowski, B., Pacholczyk, R., Kraj, P., Kisielow, P., Ignatowicz, L. (2002). Presentation of antagonist peptides to naive CD4+ T cells abrogates spatial reorganization of class II MHC peptide complexes on the surface of dendritic cells. Proc. Natl. Acad. Sci. USA 99: 15012-15017 [Abstract] [Full Text]  
• Budinger, L., Neuser, N., Totzke, U., Merk, H. F., Hertl, M. (2001). Preferential Usage of TCR-V{beta}17 by Peripheral and Cutaneous T Cells in Nickel-Induced Contact Dermatitis. J. Immunol. 167: 6038-6044 [Abstract] [Full Text]  
• Honda, S., Zhang, W., Kalergis, A. M., DiLorenzo, T. P., Wang, F., Nathenson, S. G. (2001). Hapten Addition to an MHC Class I-Binding Peptide Causes Substantial Adjustments of the TCR Structure of the Responding CD8+ T Cells. J. Immunol. 167: 4276-4285 [Abstract] [Full Text]  
• Garcia-Peydro, M., Paradela, A., Albar, J. P., Castro, J. A. L. d. (2000). Antagonism of Direct Alloreactivity of an HLA-B27-Specific CTL Clone by Altered Peptide Ligands of Its Natural Epitope. J. Immunol. 165: 5680-5685 [Abstract] [Full Text]  
• Bouhdoud, L., Villain, P., Merzouki, A., Arella, M., Couture, C. (2000). T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide. J. Virol. 74: 2121-2130 [Abstract] [Full Text]  
• Auphan, N., Ghosh, S., Flavell, R. A., Schmitt-Verhulst, A.-M. (1999). Differential Requirements for NF-{kappa}B and AP-1 trans-Activation in Response to Minimal TCR Engagement by a Partial Agonist in Naive CD8 T Cells. J. Immunol. 163: 5219-5227 [Abstract] [Full Text]  
• Huang, J., Yang, Y., Sepulveda, H., Shi, W., Hwang, I., Peterson, P. A., Jackson, M. R., Sprent, J., Cai, Z. (1999). TCR-Mediated Internalization of Peptide-MHC Complexes Acquired by T Cells. Science 286: 952-954 [Abstract] [Full Text]  
• Hin, S., Zabel, C., Bianco, A., Jung, G., Walden, P. (1999). Cutting Edge: N-Hydroxy Peptides: A New Class of TCR Antagonists. J. Immunol. 163: 2363-2367 [Abstract] [Full Text]  
• Frasca, L., Del Porto, P., Tuosto, L., Marinari, B., Scotta, C., Carbonari, M., Nicosia, A., Piccolella, E. (1999). Hypervariable Region 1 Variants Act as TCR Antagonists for Hepatitis C Virus-Specific CD4+ T Cells. J. Immunol. 163: 650-658 [Abstract] [Full Text]  
• Kessler, B., Michielin, O., Blanchard, C. L., Apostolou, I., Delarbre, C., Gachelin, G., Gregoire, C., Malissen, B., Cerottini, J.-C., Wurm, F., Karplus, M., Luescher, I. F. (1999). T Cell Recognition of Hapten. ANATOMY OF T CELL RECEPTOR BINDING OF A H-2Kd-ASSOCIATED PHOTOREACTIVE PEPTIDE DERIVATIVE. J. Biol. Chem. 274: 3622-3631 [Abstract] [Full Text]  
• Stotz, S. H., Bolliger, L., Carbone, F. R., Palmer, E. (1999). T Cell Receptor (TCR) Antagonism without a Negative Signal: Evidence from T Cell Hybridomas Expressing Two Independent TCRs. JEM 189: 253-264 [Abstract] [Full Text]  
• von Greyerz, S., Zanni, M. P., Frutig, K., Schnyder, B., Burkhart, C., Pichler, W. J. (1999). Interaction of Sulfonamide Derivatives with the TCR of Sulfamethoxazole-Specific Human {alpha}{beta}+ T Cell Clones. J. Immunol. 162: 595-602 [Abstract] [Full Text]  
• Mariathasan, S., Bachmann, M. F., Bouchard, D., Ohteki, T., Ohashi, P. S. (1998). Degree of TCR Internalization and Ca2+ Flux Correlates with Thymocyte Selection. J. Immunol. 161: 6030-6037 [Abstract] [Full Text]  
• Purbhoo, M. A., Sewell, A. K., Klenerman, P., Goulder, P. J. R., Hilyard, K. L., Bell, J. I., Jakobsen, B. K., Phillips, R. E. (1998). Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascade. Proc. Natl. Acad. Sci. USA 95: 4527-4532 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS